Mind Medicine (MindMed) Inc. (MNMD): Price and Financial Metrics
GET POWR RATINGS... FREE!
MNMD Stock Price Chart Interactive Chart >
MNMD Price/Volume Stats
| Current price | $0.87 | 52-week high | $4.04 |
| Prev. close | $0.80 | 52-week low | $0.70 |
| Day low | $0.80 | Volume | 1,950,900 |
| Day high | $0.87 | Avg. volume | 3,711,787 |
| 50-day MA | $0.93 | Dividend yield | N/A |
| 200-day MA | $1.66 | Market Cap | 368.47M |
Mind Medicine (MindMed) Inc. (MNMD) Company Bio
Mind Medicine (MindMed) Inc., a psychedelic medicine biotech company, discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances, including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC. The company is headquartered in New York, New York.
Latest MNMD News From Around the Web
Below are the latest news stories about Mind Medicine (MindMed) Inc that investors may wish to consider to help them evaluate MNMD as an investment opportunity.
MindMed Converts Multiple Voting Shares to Subordinate Voting SharesMind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (DE: MMQ) (the "Company"), a clinical-stage biopharmaceutical company developing psychedelic-inspired therapies for the treatment of brain-based disorders, announced today that all the Company's issued and outstanding multiple voting shares (the "Multiple Voting Shares") will undergo a mandatory conversion into subordinate voting shares (the "Subordinate Voting Shares") (the "Conversion"), in accordance with the Company's Articles. The Co |
Psychedelic Stock Gainers And Losers From February 15, 2022 | BenzingaGAINERS: Mind Medicine (NASDAQ: |
Why Shares of Mind Medicine Jumped 13.4% on WednesdayThe clinical-stage biopharmaceutical company benefited from an increased interest in companies working on psychedelic therapies. |
FDA Greenlight Sets the Stage for Upside With Mind MedicineFew catalysts can move healthcare stocks like a regulatory clearance can - and MNMD stock could be 2022's top psychedelics-sector investment. |
Thinking about buying stock in Velodyne Lidar, Chegg, Louisiana-Pacific Corp, Harley-Davidson, or Mind Medicine?NEW YORK , Feb. 8, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for VLDR, CHGG, LPX, HOG, and MNMD. … Full story available on Benzinga.com |
MNMD Price Returns
| 1-mo | 3.87% |
| 3-mo | -28.69% |
| 6-mo | -55.84% |
| 1-year | -74.41% |
| 3-year | N/A |
| 5-year | N/A |
| YTD | -36.96% |
| 2021 | -54.75% |
| 2020 | N/A |
| 2019 | N/A |
| 2018 | N/A |
| 2017 | N/A |
Loading social stream, please wait...